Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Many congratulations to Prof Beeson for this distinction recognising his exceptional contribution to the study of neuromuscular disorders.

Similar stories

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

NDCN

MRC WIMM researchers have revealed a population of immune cells that travel to the brain in patients with multiple sclerosis causing disease. They demonstrate how to trap these cells in the blood, meaning they can be targeted to prevent disease progression.

Angela Vincent honoured for excellence in epilepsy research

NDCN

Emeritus Professor Angela Vincent received the Research Recognition Award, clinical science, at the annual meeting of the American Epilepsy Society.

New research to investigate role of blood-brain barrier

NDCN

A new consortium of 27 partners coordinated by our researcher Prof Zameel Cader will tackle the challenge of discovery and characterisation of blood-brain barrier targets and transport mechanisms for brain delivery of therapeutics.

European licence for migraine prevention drug

NDCN

MRC WIMM research underpins the first treatment designed specifically for the prevention of migraines

World’s largest autism grant will transform research landscape

NDCN

The largest research grant ever given for neurodevelopmental conditions has been awarded by the Innovative Medicines Initiative to an international consortium that includes the participation of Prof Zameel Cader.

Oxford Centre for Neuroinflammation launched

MRC HIU NDCN

The new centre, located at the MRC WIMM, aims to shed light on the causes of neurodegenerative diseases and uncover new treatment pathways.